Research programme: pneumococcal conjugate vaccines - Chengdu Institute of Biological Products
Latest Information Update: 16 Jul 2016
At a glance
- Originator Chengdu Institute of Biological Products
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Pneumococcal infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Pneumococcal-infections in China
- 20 Aug 2012 Early research in Pneumococcal infections in China (unspecified route)